Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention.
Lihi EderKer-Ai LeeVinod ChandranJessica WiddifieldAaron M DruckerChristopher T RitchlinCheryl F RosenRichard J CookDafna D GladmanPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
The development of PsA within clinically meaningful time frames can be predicted with reasonable accuracy for psoriasis patients using readily available clinical variables.